Illness	Number of cases
Recurrent depressive disorder - Major depressive disorder recurrent severe without psychotic features (F33.2)	1.046
Depressive episode - Major depressive disorder single episode severe without psychotic features (F32.2)	667
Mental and behavioural disorders due to use of alcohol (F10.2)	387
Schizophrenia - Paranoid schizophrenia (F20.0)	344
Vascular dementia (F01.3)	126
Borderline personality disorder (F60.31)	113
Recurrent depressive disorder - Major depressive disorder recurrent severe with psychotic symptoms (F33.3)	102
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances (F19.2)	94
Reaction to severe stress and adjustment disorders - Acute stress reaction (F43.0)	60
Depressive episode - Major depressive disorder single episode severe with psychotic features (F32.3)	50

Top 10 treatments

Treatment	Number
(9-649.40)	5.952
Standard treatment for mental and psychosomatic disorders and behavioral disorders in adults (9-607)	5.262
(9-649.0)	4.823
(9-649.10)	3.888
(9-649.31)	3.422
(9-649.50)	3.279
(9-649.51)	2.061
(9-649.11)	1.593
Intensive treatment for mental and psychosomatic disorders and behavioural disorders in adult patients with one characteristic (9-617)	1.509
(9-649.30)	1.389

Further information about the department

Out-patient accident insurance doctor approval

Yes

In-patient Employers’ Liability Insurance Association approval

Yes

Department key

Department key: 2900

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
11	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
11	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
11	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Lectureships / teaching posts at universities of applied sciences
Participation in multi-centre phase III/IV studies	Es geht um den Nachweis von erwünschten Wirkungen und von Nebenwirkungen eines Medikaments.
Project-related cooperation with colleges and universities
Lectureships / teaching posts at colleges and universities